13F filer · CIK 1422848 ↗
Capital Research Global Investors
You are looking at Q2 2022. See the latest, Q2 2026 →
Reported value
$321.05B
−21% on the quarter before
Positions
423
22 new · 39 sold out
Top 10
28.6%
of the value
Est. gain
−$68.30B
on stocks held all quarter
Est. return
−18.5%
on those stocks since Q1 2022
Positions as of Jun 30, 2022, from Capital Research Global Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 46% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2022. Striped tiles are options.
Largest buys
Since Q1 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Abbvie Inc~$1.41BAdded · 0.7% → 1.3%+9,216,006 shares
- Shopify Inc~$1.09BAdded · 0.5% → 0.4%+34,799,963 shares
- Eli Lilly~$944.8MNew · 0.0% → 0.3%+2,914,107 shares
- Exxon Mobil Corp~$889.7MAdded · 0.0% → 0.3%+10,388,472 shares
- Raytheon Technologies Corp~$675.1MAdded · 1.7% → 2.2%+7,024,022 shares
- Verizon Communications Inc~$660.1MAdded · 0.2% → 0.4%+13,005,978 shares
- Starbucks Corp~$659.3MAdded · 0.2% → 0.5%+8,630,239 shares
- Tesla~$616.2MAdded · 0.2% → 0.4%+914,972 shares
- General Electric Co~$606.1MAdded · 1.7% → 1.7%+9,518,620 shares
- Nasdaq Inc~$523.7MAdded · 0.1% → 0.2%+3,433,161 shares
Largest sells
Since Q1 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Jpmorgan Chase & Co~$1.81BCut · 1.2% → 0.7%−16,078,410 shares
- Deutsche Bank A G~$1.49BSold out · 0.4% → 0.0%−117,021,869 shares
- Amgen Inc~$1.06BCut · 1.1% → 1.1%−4,336,215 shares
- Schwab Charles Corp~$1.02BCut · 0.5% → 0.2%−16,186,564 shares
- Broadcom~$965.4MCut · 3.4% → 3.1%−1,987,249 shares
- Comcast Corp New~$783.1MCut · 1.8% → 1.7%−19,955,808 shares
- MercadoLibre~$735.6MCut · 1.2% → 0.6%−1,154,959 shares
- Csx Corp~$689.0MCut · 0.7% → 0.5%−23,710,889 shares
- Netflix~$683.7MCut · 1.7% → 0.8%−3,909,720 shares
- Vale S A~$637.5MCut · 0.9% → 0.6%−43,571,786 shares
Holdings
As of Jun 30, 2022. Changes are in shares against Mar 31, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −2.4% · price −16.7% | 6.7% | $21.66B | −$4.34B | ||||||||
| AmazonCOM · shares +1.2% · price −38.1% | 3.3% | $10.65B | −$6.48B | ||||||||
| Unitedhealth Group IncCOM · shares −0.3% · price +0.7% | 3.1% | $9.87B | +$70.3M | ||||||||
| BroadcomCOM · shares −9.0% · price −22.8% | 3.1% | $9.80B | −$2.90B | ||||||||
| Abbott LabsCOM · shares −0.7% · price −8.2% | 2.7% | $8.70B | −$777.8M | ||||||||
| Raytheon Technologies CorpCOM · shares +10% · price −3.0% | 2.2% | $7.20B | −$200.9M | ||||||||
| Philip Morris Intl IncCOM · shares +0.8% · price +5.1% | 2.0% | $6.56B | +$316.2M | ||||||||
| AlphabetCAP STK CL A · shares −4.1% · price −21.6% | 1.9% | $6.17B | −$1.70B | ||||||||
| Canadian Nat Res LtdCOM · shares −8.8% · price −13.2% | 1.8% | $5.67B | −$863.2M | ||||||||
| AlphabetCAP STK CL C · shares −2.8% · price −21.7% | 1.7% | $5.53B | −$1.53B | ||||||||
| General Electric CoCOM NEW · shares +12% · price −30.4% | 1.7% | $5.52B | −$2.15B | ||||||||
| Comcast Corp NewCL A · shares −13% · price −16.2% | 1.7% | $5.31B | −$1.03B | ||||||||
| MetaCL A · shares +3.9% · price −27.5% | 1.6% | $5.01B | −$1.83B | ||||||||
| AppleCOM · shares −7.1% · price −21.7% | 1.5% | $4.94B | −$1.37B | ||||||||
| Thermo Fisher Scientific IncCOM · shares +0.6% · price −8.0% | 1.5% | $4.75B | −$411.7M | ||||||||
| Abbvie IncCOM · shares +54% · price −5.5% | 1.3% | $4.03B | −$152.9M | ||||||||
| Linde PlcSHS · shares +0.5% · price −10.0% | 1.2% | $3.96B | −$438.6M | ||||||||
| MastercardCL A · shares −13% · price −11.7% | 1.2% | $3.86B | −$512.5M | ||||||||
| Eog Res IncCOM · shares +14% · price −7.4% | 1.1% | $3.59B | −$251.1M | ||||||||
| Gilead Sciences IncCOM · shares +0.04% · price +4.0% | 1.1% | $3.46B | +$132.0M | ||||||||
| Amgen IncCOM · shares −24% · price +0.6% | 1.1% | $3.43B | +$20.9M | ||||||||
| Baker HughesCL A · shares +16% · price −20.7% | 0.98% | $3.16B | −$714.7M | ||||||||
| Carrier GlobalCOM · shares −1.0% · price −22.3% | 0.87% | $2.79B | −$797.6M | ||||||||
| General Mtrs CoCOM · shares +6.2% · price −27.4% | 0.85% | $2.74B | −$973.1M | ||||||||
| Toronto Dominion Bk OntCOM NEW · shares −19% · price −17.4% | 0.85% | $2.73B | −$572.5M | ||||||||
| Total · 423 positions | 100% | $321.05B | −$68.30B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2022 to Q2 2022: 398 stocks held throughout, down $68.30B (−18.5%).
- Philip Morris Intl Inc+$316.2M+5%
- Cenovus Energy Inc+$257.6M+14%
- General Mls Inc+$202.9M+11%
- Gilead Sciences Inc+$132.0M+4%
- Kimberly-Clark Corp+$130.8M+10%
- General Electric Co−$2.15B−30%
- Broadcom−$2.90B−23%
- Netflix−$2.97B−53%
- Microsoft−$4.34B−17%
- Amazon19:1 split−$6.48B−38%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $716.87B+11% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $644.56B+19% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $541.73B+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $532.97B+7% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $499.46B+9% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $459.90B−5% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $486.38B+1% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $481.14B+6% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $455.74B+3% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $441.98B+9% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $406.47B+12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $363.16B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $373.18B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $350.40B+6% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $330.88B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $304.37B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $321.05B−21% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $405.10B−11% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $452.67B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $428.65B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $429.52B+5% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $408.71B+6% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $385.30B+16% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $333.11B+5% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $316.13B+24% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $254.90B−24% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $333.48B+9% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $304.85B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $314.99B−0% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $315.45B+10% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $287.02B−17% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $344.02B−6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $366.12B+4% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $351.43B+3% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $340.76B+3% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $331.24B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $319.49B+1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $317.04B+3% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $308.47B+2% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $302.53B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $292.47B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $290.06B | SEC ↗ |